Labinic
Commercial- Indications
- Environmental enteric dysfunction, Gut health, Necrotising enterocolitis, Malnutrition
Company intelligence / Profile preview
Biofloratech Ltd manufactures Labinic Drops, a multispecies liquid probiotic containing Lactobacillus acidophilus, Bifidobacterium infantis, and Bifidobacterium bifidum. Labinic is manufactured in a GMP-licensed pharmacy, has an excellent safety profile, is widely used in international neonatal and paediatric care (including the NHS), and has been the subject of clinical research. Evidence indicates widespread clinical use, strong safety, and ongoing evaluation in randomized trials for prevention of infant infections and gut health.[4][5][6][7]
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Biofloratech.